Middle East and Africa Medical Cannabis Market, By Product (Oil, Medical Cannabis Capsules, Patch, Whole Flower, Ground Flower, Vape Pen, Dried Medical Cannabis, Creams & Moisturizer, Masks & Serum, Cleanser, and Others), Source (Natural and Synthetic), Species (Cannabis Indica, Sativa, and Hybrid), Application (Alzheimer’s Disease, Appetite Loss, Cancer, Inflammatory Bowel Diseases, Eating Disorders, Epilepsy, Autism, Mental Health Conditions, Multiple Sclerosis, Pain Management, Nausea, Muscle Spasms, Wasting Syndrome (Cachexia), Elevate Mood, Depression and Sleep Disorders, Anxiety, and Others), Derivatives (Cannabidiol (CBD), Tetrahydrocannabinol (THC)/ Delta-8-Tetrahydrocannabinol, Cannabinol (CBN), Cannabicyclol (CBL), Cannabichromene (CBC), Cannabigerol (CBG), and Others), Treatment Type (Expectorant, Antiviral, Analgesic, Aphrodisiac, Psychedelic, and Others), Route of Administration (Oral Solutions and Capsules, Smoking, Vaporizers, Topicals, and Others), End User (Pharmaceutical Industry, Research and Development Centers, Homecare Setting, Hospital, Rehab Centers, and Others), Distribution Channel (B2B and B2C) - Industry Trends and Forecast to 2030.
中东和非洲医药大麻市场分析和观察
与中东和非洲慢性病有关的病人人数不断增加,人们越来越倾向于健康的生活方式,这些都是预期会推动市场增长的一些因素。 此外,产品批准数量的增加和医疗用大麻装置研发活动的增加预计将推动市场增长。 然而,医疗大麻装置和程序、药用药物、安全关切和与激光程序有关的不利影响的高昂费用,以及对激光装置的治疗缺乏认识,预计将限制市场的增长。 预计新的行为者在医疗大麻方面的其他技术进步和战略举措将成为市场增长的机会。 然而,严格的条例和缺乏熟练的专业人员预计将对市场增长构成挑战。
由于政府的限制,对大麻作为药物的使用没有进行严格测试,导致在医疗和临床应用中界定大麻功效的临床研究有限. 然而,初步研究表明,大麻可以减少化疗病人的呕吐和恶心,并有助于增加食欲。
数据桥市场研究分析认为,预计在2023至2030年的预测期间,中东和非洲医药大麻市场将增长21.7%。
|
报表计量 |
细节 |
|
预测期 |
2023年至2030年统计 |
|
基准年 |
2022 |
|
历史年代 |
2021 (2015-2020年可定制) (中文(简体) ). |
|
数量单位 |
收入(百万美元) |
|
覆盖部分 |
产品(Oil, Medical Boban Capsules, Patch,全花花,地花,Vape Pen, Dried Medical Bobanbanbanbanbanbanbanbanbanbanbanbanbanbanbanbanbanbanbanbanbanbanbanbanbanbanbanbanbanbanbanbanbanbanbanbanb-s-s-s-s-s-s-s-s-s-s-s-s-s-s-s-s-s-s-s-s-s-s-s-s-s-s-s-s-s-s-s-s-s-s-s-s-s-s-s-s-s-s-s-s-s-s-s-s-s-s-s-s-s-s-s-s-s-s-s-s-s-s-s-s-s-s-s-s-s-s- |
|
涵盖国家 |
以色列、南非、黎巴嫩、美国、科威特以及中东和非洲其他地区 |
|
覆盖的市场玩家 |
MediPharm Labs Inc.、Tirray、Aurora大麻、JAZZ制药公司、HEXO公司(Zenabis中东和非洲有限公司)、Cresco实验室、和平自然项目公司、CANOPY GROWTH CORPOLATION、医疗大麻公司、Seed Cellar、生态基因生物科学、CANNABIS SEEDS 美国、Seeds For Me、HUMBOLDT SEED COMPANY、Extrastics、世界级大麻种子(Crop King Seids)、BARnyy'S FARM、FOLULIUM BIOSCIENES、PHEMP、Elixinol中东和非洲有限公司、ENDOCA、和谐公司、MARYS营养公司、LC、Pure Rapers、Grewich生物科学公司、Uppate Elevator供应公司、Apothecannana、BOL Pharma公司和IDT Aust Aust Aust Aust Aust Aust有限公司等 |
市场定义
大麻是一种从Cannabaceae家族大麻植物中衍生出来的精神活性药物。 几年来,它一直被药用,在治疗包括慢性疼痛,癌症,抑郁症,糖尿病,关节炎,青光眼,癫痫,偏头痛,艾滋病,阿尔茨海默等各种疾病方面有广泛的应用.
大麻药用增加、大麻在各行业的管制合法化和使用以及该领域现有的先进方法,是预期能推动市场增长的一些因素。
中东和非洲医药大麻市场动态
本节讨论了解市场驱动力、优势、机会、制约因素和挑战。 详细讨论这一切如下:
司机
- 药物中大麻的使用增加
药用大麻出自大麻植物,可以用于治疗某些病情的症状和一些治疗的副作用. 大麻药用最常见的形式是疼痛管理. 药用大麻已逐渐被接受和使用,越来越多的国家将大麻用于各种指示剂合法化。 药用大麻已被FDA批准用于三种罕见而严重的癫痫症状 -- -- Dravet综合征和Lennox-Gastaut综合征 -- -- 并用于治疗多发性硬化症(MS)的挥发性。
医用大麻用大麻植物或其中的化学品治疗除批准药物以外的疾病或情况,对两种大麻酚的兴趣增加,一种是三角-9-四氢大麻酚和大麻酚。 显示四氢大麻酚可以改善胃口,将疲劳降到最低,并管理肌肉功能问题,而大麻酚则能有效地管理癫痫发作,治疗精神病并减少炎症.
- 大麻的合法化
药用大麻的使用和接受情况继续发生变化,因为越来越多的国家允许使用特定的医学标志。 许多国家为药用或娱乐目的将大麻合法化,而另一些国家则限制使用大麻。 近年来,美国越来越多的州为了医疗或娱乐目的将该药物合法化. 随着大麻的广泛合法化,许多公司也开始采取主动,并正在采取主动行动使大麻完全合法化。
大麻在世界不同地区的合法化可被视为是增加额外收入的一种努力,这样,在不提高税收的情况下,收入将会增加。 大麻的合法化将使更多的大麻用于医药或娱乐目的。 此外,这也将促进大麻业务,从而产生更多的大麻需求。 因此,预期大麻合法化将推动市场增长。
机会
- 研发活动增加的新产品开发
药用大麻有多种不同形式,包括胶囊、可嚼口香糖、奶油、晶体、花卉、洛桑果、油和奥罗-穆科斯喷雾剂。 随着合法化,对大麻需求的高增长使得更有必要建立更好的产品品种和交货系统。 这导致许多公司开展研发活动,以检查大麻的基因改良战略。 林业发展局的大麻产品委员会制定并实施管制大麻产品的跨机构战略和政策。 所开发出并正在兴起的新产品有:hemp蛋白粉,能条,hemp牛奶,hemp面粉,和hemp茶等,这些产品有望为市场增长创造出机会.
- 为娱乐目的更多地采用大麻
将娱乐性大麻合法化有助于对安全药物进行监管,而不会增加潜在的不良后果。 大麻的合法化具有各种社会效益,因为经济的上升没有增加税收,创造了上千个就业机会,制止了大麻执法中的种族差异,并释放出稀缺的警察资源. 合法的娱乐性大麻可以结束昂贵的大麻执法,并削弱非法的大麻市场。
由于这些好处,大麻已经合法化,并越来越多地被不同年龄组的人所采用。 这就产生了对优质大麻的追求,以取乐和放松. 因此,为娱乐目的越来越多地采用大麻预计将为市场上的制造商创造机会。
限制/挑战
- 高成本采购和急于购买保费质量
医疗用大麻装置的制造和购买费用可能很高,由于需要专门设备和培训,程序费用也可能很高。 这可能会限制患者和保健设施获得大麻医疗的机会,特别是在低收入地区。 此外,医疗用大麻装置和程序的高昂费用可能阻止一些病人选择这些治疗方法,特别是如果他们必须自费支付的话。 大麻医疗的保险范围也可能有限,限制了其采用。
因此,医疗大麻装置和程序的高成本可能成为市场增长的重大障碍,特别是在成本是主要因素的地区。 然而,随着技术的进步,这些装置和程序的成本可能会下降,从而使病人和保健设施更容易获得这些装置和程序。
医疗用大麻装置日益复杂,医疗用大麻治疗费用高,预计会抑制市场增长。
最近的发展
- 2018年5月,根据加拿大政府的《大麻法》,《大麻法》将为在加拿大各地控制大麻的生产、分销、销售和拥有建立一个严格的法律框架,其目的是通过促进强有力的合法和受管制的行业,使大麻不落入青年之手,使有组织犯罪的口袋中获利。
中东和非洲医药大麻市场范围
中东和非洲医疗大麻市场按产品、来源、物种、衍生物、应用、管理路线、治疗类型、最终用户和分销渠道分为9个显著部分。 这些部门的增长将帮助你分析这些行业的市场增长部分,并向用户提供宝贵的市场概况和市场见解,帮助他们作出确定核心市场应用的战略决定。
产品
- 石油
- 干药用大麻
- 医用大麻盖
- 阴道笔
- 全花开
- 奶油和润滑剂
- 地面花朵
- 补丁
- 遮盖和血清
- 清理器
- 其他人员
以产品为基础,市场被分割成油类,医用大麻胶囊,补丁类,全花类,地花类,活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活活.
来源
- 合成
- 自然性质
在来源的基础上,市场被分解为合成和自然.
物种
- 大麻指数
- 萨蒂瓦
- 混合
在物种的基础上,市场被分入了大麻 Indica, sativa和杂交种.
衍生物
- Cannabidiol(《生物多样性公约》)
- 四氢大麻酚/三角洲-8-四氢大麻酚
- 坎纳比格尔醇(CBG)
- Canabichromene(化学文摘社)
- 坎纳比醇 (CBN)
- Cannabi环形山( CBL)
- 其他人员
以衍生物为基础,将市场分入Cannabidiol(CBD),四氢大麻酚(THC)/delta-8-四氢大麻酚(CBN),Cannabicyclol(CBL),Cannabichromene(CBC),Cannabigerol(CBG)等.
应用
- 疼痛管理
- 焦虑
- 肌肉螺丝
- 恶心
- 用户损失
- 饮食失调
- 发炎性肠道疾病
- 癌症
- 关节炎
- 浪费综合症(卡切克夏)
- 阿尔茨海默病
- 癫痫
- 抑郁症和睡眠障碍
- 多重硬化症
- 自闭症
- 心理健康条件
- 高地摩德语
- 其他人员
在应用的基础上,市场被划分为阿尔茨海默症、食欲丧失、癌症、发炎性肠道疾病、饮食障碍、癫痫、自闭症、心理健康状况、多发性硬化、疼痛管理、恶心、肌肉痉挛、消瘦综合症(cachexia)、情绪升高、多发性硬化、抑郁和睡眠失调、焦虑等。
行政路线
- 口服溶液和口罩
- 吸烟
- 蒸发器
- 专题
- 其他人员
根据管理路线,市场分为口服溶液和胶囊、吸烟、蒸发剂、热点等。
治疗类型
- 镇痛药
- 迷幻药
- 抗病毒药
- 恶作剧
- 预测者
- 其他人员
根据治疗类型,市场被划分为预期剂,抗病毒药,止痛药,止痛药,迷幻药等.
结束用户
- 家庭护理设置
- 医院
- 康复中心
- 制药业
- 研究和发展中心
- 其他人员
在最终用户的基础上,市场分为制药业、研发中心、家庭护理环境、医院、康复中心等。
分发频道
- B2B级
- 溴化二苯醚
根据发行渠道,将市场分入B2B和B2C.
中东和非洲医药大麻市场区域分析/见解
中东和非洲医疗大麻市场按产品、来源、物种、衍生物、应用、管理路线、治疗类型、最终用户和分销渠道分为9个显著部分。
本市场报告涵盖的国家有:以色列,南非,黎巴嫩,美国,科威特,以及中东和非洲其他地区.
由于该国研发活动的增加,预计以色列将主导中东和非洲医药大麻市场。
报告的国家部分还提供了影响市场的因素和国内市场监管的变化,这些变化影响到市场目前和未来的趋势。 诸如新的销售、替代销售、国家人口统计、监管法和进出口关税等数据点是用来预测个别国家市场情况的一些主要指针。 此外,在对国家数据进行预测分析的同时,还考虑了区域品牌的存在和可得性以及它们因来自当地和国内品牌的大规模或稀缺竞争而面临的挑战,以及销售渠道的影响。
竞争性景观与中东和非洲医药大麻市场份额分析
中东和非洲医药大麻市场竞争环境提供了竞争者的详细情况。 详细情况包括公司概况、公司财务、创收、市场潜力、研发投资、新市场举措、区域存在、生产地点和设施、公司优势和弱点、产品推出、临床试验管道、品牌分析、产品审批、专利、产品宽度和广度、应用优势和技术生命线曲线。 上述数据点只涉及公司与市场有关的重点。
在这个市场上经营的一些主要市场参与者有:MediPharm Labs Inc.、Tilray、Aurora大麻、JAZZ制药公司(GW制药plc)、HEXO公司(Zenabis中东和非洲有限公司)、Cresco实验室、和平自然项目公司、CANOPY GROWTH CORPORLATION、Medical Marijuana Inc.、Seed Cellar、EcoGen生物科学、CANNABIS SEIDS美国、SEids For Me、HUMBOLLD SED COMPANY、Extras、世界级大麻种子(Crop King Seeds)、BARNEY'S FARM、FLIUM BIOSCIENS、P、Elixinol中东和非洲有限公司、ENDOCA、和谐、MARYS营养、LOC、PC、纯比率公司、格林威克生物科学公司、上州Elevator供应公司、Apothecannana、BOL Pharma等。
SKU-
目录
1 引言
1.1 研究目標
1.2 市場定義
1.3 中東和非洲醫用大麻市場概況
1.4 限制
1.5 覆蓋市場
2 市場區隔
2.1 覆蓋市場
2.2 地理範圍
研究需時 2.3 年
2.4 貨幣和定價
2.5 DBMR三腳架資料驗證模型
2.6 多變量建模
2.7 產品生命線曲線
2.8 與關鍵意見領袖的初步訪談
2.9 DBMR 市場地位網格
2.1 市場應用覆蓋網格
2.11 供應商份額分析
2.12 第二手資料
2.13 假設
3 執行摘要
4 項優質見解
4.1 佩爾斯特分析
4.2 波特五力模型
5 產業洞察
5.1 產業洞察專利分析
5.2 成熟市場的藥物治療率
5.3 人口趨勢：對所有發病率的影響
5.4 患者流程圖
5.5 關鍵定價策略
5.6 關鍵患者入組策略
6 監管情景
6.1 南非
6.2 阿聯酋
7 市場概覽
7.1 驅動程式
7.1.1 大麻在醫藥中的使用增加
7.1.2 大麻合法化
7.1.3 主要參與者所採取的策略性舉措
7.1.4 需要使用大麻的疾病盛行率上升
7.2 限制
7.2.1 大麻使用的複雜監管結構
7.2.2 長期使用所引起的不良反應
7.2.3 高成本採購，追求高品質
7.3 機遇
7.3.1 新產品開發，研發活動不斷增加
7.3.2 娛樂用途大麻的使用增加
7.3.3 老年人口不斷成長
7.4 挑戰
7.4.1 大麻黑市的興起
7.4.2 與使用大麻有關的副作用
7.4.3 技能人才短缺
8 中東和非洲醫用大麻市場（按產品）
8.1 概述
8.2 石油
8.2.1 石油（按類型）
8.2.1.1 CBD油濃縮物
8.2.1.2 CBD電子煙油
8.2.1.3 CBD酊劑
8.2.2 石油，依來源
8.2.2.1 大麻基
8.2.2.2 大麻類
8.2.3 石油（依種類）
8.2.3.1 苜蓿
8.2.3.2 混合
8.2.3.3 印度大麻
8.2.4 石油，依產品類型
8.2.4.1 品牌
8.2.4.1.1 企鵝CBD油
8.2.4.1.2 FAB CBD油
8.2.4.1.3 GREEN ROADS 廣譜 CBD 油
8.2.4.1.4 其他
8.2.4.2 通用
8.3 乾燥醫用大麻
8.3.1 印度大麻
8.3.2 苜蓿
8.3.3 混合
8.4 醫用大麻膠囊
8.4.1 醫用大麻膠囊（依類型）
8.4.1.1 油基大麻膠囊
8.4.1.2 粉狀大麻膠囊
8.4.1.3 液體大麻膠囊
8.4.1.4 其他
8.4.2 醫用大麻膠囊（依濃縮物）
8.4.2.1 高 CBD 膠囊數位版
8.4.2.2 高THC膠囊
8.4.2.3 THC/CBD平衡膠囊
8.4.2.4 CBD分離膠囊
8.4.3 醫用大麻膠囊（依種類）
8.4.3.1 苜蓿
8.4.3.2 印度大麻
8.4.4 醫用大麻膠囊（依產品類型）
8.4.4.1 品牌
8.4.4.1.1 快樂營養
8.4.4.1.2 MEDTERRA 分離 CBD 凝膠膠囊
8.4.4.1.3 拉撒路自然
8.4.4.1.4 其他
8.4.4.2 通用
8.5 電子煙
8.5.1 電子煙，依種類
8.5.1.1 苜蓿
8.5.1.2 混合
8.5.1.3 印度大麻
8.5.2 電子煙，依產品類型
8.5.2.1 品牌
8.5.2.1.1 康迪彭斯‧魯比
8.5.2.1.2 SOL E-NECTAR 收集器
8.5.2.1.3 PAX ERA PRO-OIL 電子煙筆
8.5.2.2 通用
8.6 整朵花
8.6.1 整朵花，種類
8.6.1.1 苜蓿
8.6.1.2 混合
8.6.1.3 印度大麻
8.6.2 整花，產品類型
8.6.2.1 品牌
8.6.2.1.1 紫苑農場
8.6.2.1.2 RA 花
8.6.2.1.3 壞蘋果
8.6.2.2 通用
8.7 乳霜和保濕霜
8.7.1 乳霜和保濕霜（依種類）
8.7.1.1 苜蓿
8.7.1.2 混合
8.7.1.3 印度大麻
8.7.2 乳霜和保濕霜，依產品類型
8.7.2.1 品牌
8.7.2.1.1 CBDFX 肌肉和關節
8.7.2.1.2 ASPEN GREEN 肌肉舒緩清涼霜
8.7.2.1.3 MEDTERRA 止痛膏
8.7.2.2 通用
8.8 地花
8.8.1 地上花卉（依種類）
8.8.1.1 苜蓿
8.8.1.2 混合
8.8.1.3 印度大麻
8.8.2 地花，依產品類型
8.8.2.1 品牌
8.8.2.1.1 紫苑農場
8.8.2.1.2 RA 花
8.8.2.1.3 壞蘋果
8.8.2.2 通用
8.9補丁
8.9.1 補丁（按類型）
8.9.1.1 水庫
8.9.1.2 黏合劑中的藥物層
8.9.1.3 其他
8.9.2 斑塊，依物種
8.9.2.1 苜蓿
8.9.2.2 印度大麻
8.9.2.3 混合
8.9.3 補丁（依產品類型）
8.9.3.1 品牌
8.9.3.1.1 大麻炸彈
8.9.3.1.2 普雷卡納
8.9.3.1.3 純比例
8.9.3.1.4 水庫
8.9.3.2 通用
8.1 面膜和精華液
8.10.1 面膜和精華液（依種類）
8.10.1.1 苜蓿
8.10.1.2 印度大麻
8.10.1.3 混合
8.10.2 面膜和精華液，依產品類型
8.10.2.1 品牌
8.10.2.1.1 碰撞與平滑CBD
8.10.2.1.2 臉部精華
8.10.2.1.3 其他
8.10.2.2 通用
8.11 潔面乳
8.11.1 清潔劑（依種類）
8.11.1.1 苜蓿
8.11.1.2 混合
8.11.1.3 印度大麻
8.11.2 清潔劑（依產品類型）
8.11.2.1 品牌
8.11.2.1.1 科顏氏
8.11.2.1.2 CBD 101
8.11.2.1.3 其他
8.11.2.2 通用
8.12 其他
9 中東和非洲醫用大麻市場（按品種劃分）
9.1 概述
9.2 苜蓿
9.3 混合
9.4 印度大麻
10 中東和非洲醫用大麻市場（按衍生性商品劃分）
10.1 概述
10.2 大麻二酚（CBD）
10.3 四氫大麻酚（THC）/δ-8-四氫大麻酚
10.4 大麻萜酚（CBG）
10.5 大麻色素（CBC）
10.6 大麻酚（CBN）
10.7 大麻環醇（CBL）
10.8 其他
11 中東和非洲醫用大麻市場（按應用）
11.1 概述
11.2 疼痛管理
11.2.1 疼痛管理（按類型）
11.2.1.1 慢性疼痛
11.2.1.2 非癌症慢性疼痛
11.2.1.3 神經性疼痛
11.2.2 疼痛管理（副產品）
11.2.2.1 石油
11.2.2.2 乾燥醫用大麻
11.2.2.3 醫用大麻膠囊
11.2.2.4 補丁
11.2.2.5 地花
11.2.2.6 乳霜和保濕霜
11.2.2.7 電子煙
11.2.2.8 整朵花
11.2.2.9 面膜和精華液
11.2.2.10 清潔劑
11.2.2.11 其他
11.3 焦慮
11.3.1 石油
11.3.2 乾燥醫用大麻
11.3.3 醫用大麻膠囊
11.3.4 補丁
11.3.5 地花
11.3.6 乳霜和保濕霜
11.3.7 電子煙
11.3.8 整朵花
11.3.9 面膜和精華液
11.3.10 清潔劑
11.3.11 其他
11.4 肌肉痙攣
11.4.1 石油
11.4.2 乾燥醫用大麻
11.4.3 醫用大麻膠囊
11.4.4 補丁
11.4.5 地花
11.4.6 乳霜和保濕霜
11.4.7 電子煙
11.4.8 整朵花
11.4.9 面膜和精華液
11.4.10 清潔劑
11.4.11 其他
11.5 噁心
11.5.1 石油
11.5.2 乾燥醫用大麻
11.5.3 醫用大麻膠囊
11.5.4 補丁
11.5.5 地花
11.5.6 面霜和保濕霜
11.5.7 電子煙
11.5.8 整朵花
11.5.9 面膜和精華液
11.5.10 清潔劑
11.5.11 其他
11.6 食慾不振
11.6.1 石油
11.6.2 乾燥醫用大麻
11.6.3 醫用大麻膠囊
11.6.4 補丁
11.6.5 地花
11.6.6 乳霜和保濕霜
11.6.7 電子煙
11.6.8 整朵花
11.6.9 面膜和精華液
11.6.10 清潔劑
11.6.11 其他
11.7 飲食失調
11.7.1 石油
11.7.2 乾燥醫用大麻
11.7.3 醫用大麻膠囊
11.7.4 補丁
11.7.5 地花
11.7.6 乳霜和保濕霜
11.7.7 電子煙
11.7.8 整朵花
11.7.9 面膜和精華液
11.7.10 清潔劑
11.7.11 其他
11.8 發炎性腸道疾病
11.8.1 石油
11.8.2 乾燥醫用大麻
11.8.3 醫用大麻膠囊
11.8.4 補丁
11.8.5 地花
11.8.6 乳霜和保濕霜
11.8.7 電子煙
11.8.8 整朵花
11.8.9 面膜和精華液
11.8.10 清潔劑
11.8.11 其他
11.9 癌症
11.9.1 石油
11.9.2 乾燥醫用大麻
11.9.3 醫用大麻膠囊
11.9.4 補丁
11.9.5 地花
11.9.6 乳霜和保濕霜
11.9.7 電子煙
11.9.8 整朵花
11.9.9 面膜和精華液
11.9.10 清潔劑
11.9.11 其他
11.1 關節炎
11.10.1 石油
11.10.2 乾燥醫用大麻
11.10.3 醫用大麻膠囊
11.10.4補丁
11.10.5 地花
11.10.6 乳霜和保濕霜
11.10.7 電子煙
11.10.8 整朵花
11.10.9 面膜和精華液
11.10.10 潔面乳
11.10.11 其他
11.11 洗滌症候群（惡病質）
11.11.1 石油
11.11.2 乾燥醫用大麻
11.11.3 醫用大麻膠囊
11.11.4補丁
11.11.5 地花
11.11.6 乳霜和保濕霜
11.11.7 電子煙
11.11.8 整朵花
11.11.9 面膜和精華液
11.11.10 潔面乳
11.11.11 其他
11.12 阿茲海默症
11.12.1 石油
11.12.2 乾燥醫用大麻
11.12.3 醫用大麻膠囊
11.12.4補丁
11.12.5 地花
11.12.6 乳霜和保濕霜
11.12.7 電子煙
11.12.8 整朵花
11.12.9 面膜和精華液
11.12.10 潔面乳
11.12.11 其他
11.13 癲癇
11.13.1 石油
11.13.2 乾燥醫用大麻
11.13.3 醫用大麻膠囊
11.13.4補丁
11.13.5 地花
11.13.6 乳霜和保濕霜
11.13.7 電子煙
11.13.8 整朵花
11.13.9 面膜和精華液
11.13.10 潔面乳
11.13.11 其他
11.14 憂鬱症和睡眠障礙
11.14.1 石油
11.14.2 乾燥醫用大麻
11.14.3 醫用大麻膠囊
11.14.4補丁
11.14.5 地花
11.14.6 乳霜和保濕霜
11.14.7 電子煙
11.14.8 整朵花
11.14.9 面膜和精華液
11.14.10 潔面乳
11.14.11 其他
11.15 多發性硬化症
11.15.1 石油
11.15.2 乾燥醫用大麻
11.15.3 醫用大麻膠囊
11.15.4補丁
11.15.5 地花
11.15.6 乳霜和保濕霜
11.15.7 電子煙
11.15.8 整朵花
11.15.9 面膜和精華液
11.15.10 潔面乳
11.15.11 其他
11.16 自閉症
11.16.1 石油
11.16.2 乾燥醫用大麻
11.16.3 醫用大麻膠囊
11.16.4補丁
11.16.5 地花
11.16.6 乳霜和保濕霜
11.16.7 電子煙
11.16.8 整朵花
11.16.9 面膜和精華液
11.16.10 潔面乳
11.16.11 其他
11.17 精神健康狀況
11.17.1 精神健康狀況（按類型）
11.17.1.1 創傷後壓力症候群（PTSD）
11.17.1.2 精神分裂症
11.17.1.3 其他
11.17.2 精神健康狀況（按類型）
11.17.2.1 石油
11.17.2.2 乾燥醫用大麻
11.17.2.3 醫用大麻膠囊
11.17.2.4 補丁
11.17.2.5 地花
11.17.2.6 乳霜和保濕霜
11.17.2.7 電子煙
11.17.2.8 整朵花
11.17.2.9 面膜和精華液
11.17.2.10 清潔劑
11.17.2.11 其他
11.18 提升心情
11.18.1 石油
11.18.2 乾燥醫用大麻
11.18.3 醫用大麻膠囊
11.18.4補丁
11.18.5 地花
11.18.6 乳霜和保濕霜
11.18.7 電子煙
11.18.8 整朵花
11.18.9 面膜和精華液
11.18.10 潔面乳
11.18.11 其他
11.19 其他
12 中東和非洲醫用大麻市場（依給藥途徑）
12.1 概述
12.2 口服溶液和膠囊
12.3 吸煙
12.4 外用藥
12.5 汽化器
12.6 其他
13 中東和非洲醫用大麻市場（按治療類型）
13.1 概述
13.2 鎮痛藥
13.3 迷幻
13.4 抗病毒藥物
13.5 春藥
13.6 祛痰藥
13.7 其他
14 中東和非洲醫用大麻市場（按最終用戶劃分）
14.1 概述
14.2 家庭照護環境
14.3 醫院
14.4 復健中心
14.5 製藥業
14.6 研發中心
14.7 其他
15 中東和非洲醫用大麻市場（按分銷管道劃分）
15.1 概述
15.2 B2C
15.2.1 藥局
15.2.2 傳統商店
15.2.3 網上商店
15.2.4 其他
15.3 B2B
16 中東和非洲醫用大麻市場（按地區）
16.1 中東和非洲
16.1.1 以色列
16.1.2 南非
16.1.3 黎巴嫩
16.1.4 阿聯酋
16.1.5 科威特
16.1.6 中東和非洲其他地區
17 中東和非洲醫用大麻市場：公司格局
17.1 公司份額分析：中東和非洲
18 公司簡介
18.1 MEDIPHARM 實驗室公司
18.1.1 公司概況
18.1.2 收入分析
18.1.3 公司股份分析
18.1.4 產品組合
18.1.5 近期發展
18.2 蒂爾雷
18.2.1 公司概況
18.2.2 公司股份分析
18.2.3 產品組合
18.2.4 近期發展
18.3 極光大麻
18.3.1 公司概況
18.3.2 收入分析
18.3.3 公司股份分析
18.3.4 產品組合
18.3.5 近期發展
18.4 JAZZ PHARMACEUTICALS INC.（GW PHARMACEUTICALS PLC）
18.4.1 公司概況
18.4.2 收入分析
18.4.3 公司股份分析
18.4.4 產品組合
18.4.5 近期發展
18.5 HEXO 公司（ZENABIS 中東和非洲有限公司）
18.5.1 公司概況
18.5.2 收入分析
18.5.3 公司股份分析
18.5.4 產品組合
18.5.5 近期發展
18.6 藥劑師
18.6.1 公司概況
18.6.2 產品組合
18.6.3 最近的發展
18.7 博爾製藥
18.7.1 公司概況
18.7.2 產品組合
18.7.3 近期發展
18.8 巴尼農場
18.8.1 公司概況
18.8.2 產品組合
18.8.3 近期發展
18.9 冠層生長公司
18.9.1 公司概況
18.9.2 收入分析
18.9.3 產品組合
18.9.4 近期發展
18.1 美國大麻種子
18.10.1 公司概況
18.10.2 產品組合
18.10.3 最近的發展
18.11 CRESCO實驗室
18.11.1 公司概況
18.11.2 產品組合
18.11.3 近期發展
18.12 生態生物科學
18.12.1 公司概況
18.12.2 產品組合
18.12.3 近期發展
18.13 ELIXINOL中東和非洲有限公司
18.13.1 公司概況
18.13.2 收入分析
18.13.3 產品組合
18.13.4 近期發展
18.14 內視鏡
18.14.1 公司概況
18.14.2 產品組合
18.14.3 最近的發展
18.15 萃取物
18.15.1 公司概況
18.15.2 產品組合
18.15.3 最近的發展
18.16 FOLIUM BIOSCIENCES
18.16.1 公司概況
18.16.2 產品組合
18.16.3 近期發展
18.17 格林威治生物科學公司
18.17.1 公司概況
18.17.2 產品組合
18.17.3 近期發展
18.18 和諧
18.18.1 公司概況
18.18.2 產品組合
18.18.3 近期發展
18.19 洪堡種子公司
18.19.1 公司概況
18.19.2 產品組合
18.19.3 最近的發展
18.2 IDT 澳大利亞
18.20.1 公司概況
18.20.2 收入分析
18.20.3 產品組合
18.20.4 近期發展
18.21 瑪麗營養有限公司
18.21.1 公司概況
18.21.2 產品組合
18.21.3 最近的發展
18.22 醫用大麻公司
18.22.1 公司概況
18.22.2 收入分析
18.22.3 產品組合
18.22.4 近期發展
18.23 和平自然專案公司
18.23.1 公司概況
18.23.2 產品組合
18.23.3 最近的發展
18.24 藥用大麻
18.24.1 公司概況
18.24.2 產品組合
18.24.3 最近的發展
18.25 純比例
18.25.1 公司概況
18.25.2 產品組合
18.25.3 最近的發展
18.26 種子給我
18.26.1 公司概況
18.26.2 產品組合
18.26.3 最近的發展
18.27 種子窖
18.27.1 公司概況
18.27.2 產品組合
18.27.3 最近的發展
18.28 上州電梯供應公司
18.28.1 公司概況
18.28.2 產品組合
18.28.3 最近的發展
18.29 世界級大麻種子（CROP KING SEEDS）
18.29.1 公司概況
18.29.2 產品組合
18.29.3 最近的發展
19 問卷
20份相關報告
表格列表
TABLE 1 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 2 MIDDLE EAST & AFRICA OIL IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 3 MIDDLE EAST & AFRICA OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 4 MIDDLE EAST & AFRICA OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 5 MIDDLE EAST & AFRICA OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 6 MIDDLE EAST & AFRICA OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION)
TABLE 7 MIDDLE EAST & AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 8 MIDDLE EAST & AFRICA DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 9 MIDDLE EAST & AFRICA DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 10 MIDDLE EAST & AFRICA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 11 MIDDLE EAST & AFRICA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 12 MIDDLE EAST & AFRICA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)
TABLE 13 MIDDLE EAST & AFRICA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 14 MIDDLE EAST & AFRICA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 15 MIDDLE EAST & AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 16 MIDDLE EAST & AFRICA VAPE PEN IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 17 MIDDLE EAST & AFRICA VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 18 MIDDLE EAST & AFRICA VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 19 MIDDLE EAST & AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 20 MIDDLE EAST & AFRICA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 21 MIDDLE EAST & AFRICA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 22 MIDDLE EAST & AFRICA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 23 MIDDLE EAST & AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 24 MIDDLE EAST & AFRICA CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 25 MIDDLE EAST & AFRICA CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 26 MIDDLE EAST & AFRICA CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 27 MIDDLE EAST & AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 28 MIDDLE EAST & AFRICA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 29 MIDDLE EAST & AFRICA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 30 MIDDLE EAST & AFRICA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 31 MIDDLE EAST & AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 32 MIDDLE EAST & AFRICA PATCH IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 33 MIDDLE EAST & AFRICA PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 34 MIDDLE EAST & AFRICA PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 35 MIDDLE EAST & AFRICA PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 36 MIDDLE EAST & AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 37 MIDDLE EAST & AFRICA MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 38 MIDDLE EAST & AFRICA MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 39 MIDDLE EAST & AFRICA MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 40 MIDDLE EAST & AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 41 MIDDLE EAST & AFRICA CLEANSER IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 42 MIDDLE EAST & AFRICA CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 43 MIDDLE EAST & AFRICA CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 44 MIDDLE EAST & AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 45 MIDDLE EAST & AFRICA OTHERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 46 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 47 MIDDLE EAST & AFRICA SATIVA IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 48 MIDDLE EAST & AFRICA HYBRID IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 49 MIDDLE EAST & AFRICA CANNABIS INDICA IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 50 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)
TABLE 51 MIDDLE EAST & AFRICA CANNABIDIOL (CBD) IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 52 MIDDLE EAST & AFRICA TETRAHYDROCANNABINOL (THC)/DELTA-8-TETRAHYDROCANNABINOL IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 53 MIDDLE EAST & AFRICA CANNABIGEROL (CBG) IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 54 MIDDLE EAST & AFRICA CANNABICHROMENE (CBC) IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 55 MIDDLE EAST & AFRICA CANNABINOL (CBN) IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 56 MIDDLE EAST & AFRICA CANNABICYCLOL (CBL) IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 57 MIDDLE EAST & AFRICA OTHERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 58 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 59 MIDDLE EAST & AFRICA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 60 MIDDLE EAST & AFRICA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 61 MIDDLE EAST & AFRICA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 62 MIDDLE EAST & AFRICA ANXIETY IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 63 MIDDLE EAST & AFRICA ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 64 MIDDLE EAST & AFRICA MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 65 MIDDLE EAST & AFRICA MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 66 MIDDLE EAST & AFRICA NAUSEA IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 67 MIDDLE EAST & AFRICA NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 68 MIDDLE EAST & AFRICA APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 69 MIDDLE EAST & AFRICA APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 70 MIDDLE EAST & AFRICA EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 71 MIDDLE EAST & AFRICA EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 72 MIDDLE EAST & AFRICA INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 73 MIDDLE EAST & AFRICA INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 74 MIDDLE EAST & AFRICA CANCER IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 75 MIDDLE EAST & AFRICA CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 76 MIDDLE EAST & AFRICA ARTHRITIS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 77 MIDDLE EAST & AFRICA ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 78 MIDDLE EAST & AFRICA WASHING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 79 MIDDLE EAST & AFRICA WASHING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 80 MIDDLE EAST & AFRICA ALZHEIMER’S DISEASE IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 81 MIDDLE EAST & AFRICA ALZHEIMER’S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 82 MIDDLE EAST & AFRICA EPILEPSY IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 83 MIDDLE EAST & AFRICA EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 84 MIDDLE EAST & AFRICA DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 85 MIDDLE EAST & AFRICA DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 86 MIDDLE EAST & AFRICA MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 87 MIDDLE EAST & AFRICA MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 88 MIDDLE EAST & AFRICA AUTISM IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 89 MIDDLE EAST & AFRICA AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 90 MIDDLE EAST & AFRICA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 91 MIDDLE EAST & AFRICA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 92 MIDDLE EAST & AFRICA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 93 MIDDLE EAST & AFRICA ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 94 MIDDLE EAST & AFRICA ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 95 MIDDLE EAST & AFRICA OTHERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 96 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)
TABLE 97 MIDDLE EAST & AFRICA ORAL SOLUTIONS AND CAPSULES IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 98 MIDDLE EAST & AFRICA SMOKING IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 99 MIDDLE EAST & AFRICA TOPICALS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 100 MIDDLE EAST & AFRICA VAPORIZERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 101 MIDDLE EAST & AFRICA OTHERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 102 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 103 MIDDLE EAST & AFRICA ANALGESIC IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 104 MIDDLE EAST & AFRICA PSYCHEDELIC IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 105 MIDDLE EAST & AFRICA ANTIVIRAL IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 106 MIDDLE EAST & AFRICA APHRODISIAC IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 107 MIDDLE EAST & AFRICA EXPECTORANT IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 108 MIDDLE EAST & AFRICA OTHERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 109 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 110 MIDDLE EAST & AFRICA HOMECARE SETTING IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 111 MIDDLE EAST & AFRICA HOSPITAL IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 112 MIDDLE EAST & AFRICA REHAB CENTERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 113 MIDDLE EAST & AFRICA PHARMACEUTICAL INDUSTRY IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 114 MIDDLE EAST & AFRICA RESEARCH AND DEVELOPMENT CENTERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 115 MIDDLE EAST & AFRICA OTHERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 116 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 117 MIDDLE EAST & AFRICA B2C IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 118 MIDDLE EAST & AFRICA B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 119 MIDDLE EAST & AFRICA B2B IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 120 MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 121 MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 122 MIDDLE EAST AND AFRICA OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 123 MIDDLE EAST AND AFRICA OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 124 MIDDLE EAST AND AFRICA OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 125 MIDDLE EAST AND AFRICA OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 126 MIDDLE EAST AND AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 127 MIDDLE EAST AND AFRICA DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 128 MIDDLE EAST AND AFRICA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 129 MIDDLE EAST AND AFRICA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)
TABLE 130 MIDDLE EAST AND AFRICA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 131 MIDDLE EAST AND AFRICA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 132 MIDDLE EAST AND AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 133 MIDDLE EAST AND AFRICA VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 134 MIDDLE EAST AND AFRICA VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 135 MIDDLE EAST AND AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 136 MIDDLE EAST AND AFRICA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 137 MIDDLE EAST AND AFRICA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 138 MIDDLE EAST AND AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 139 MIDDLE EAST AND AFRICA CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 140 MIDDLE EAST AND AFRICA CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 141 MIDDLE EAST AND AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 142 MIDDLE EAST AND AFRICA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 143 MIDDLE EAST AND AFRICA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 144 MIDDLE EAST AND AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 145 MIDDLE EAST AND AFRICA PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 146 MIDDLE EAST AND AFRICA PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 147 MIDDLE EAST AND AFRICA PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 148 MIDDLE EAST AND AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 149 MIDDLE EAST AND AFRICA MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 150 MIDDLE EAST AND AFRICA MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 151 MIDDLE EAST AND AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 152 MIDDLE EAST AND AFRICA CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 153 MIDDLE EAST AND AFRICA CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 154 MIDDLE EAST AND AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 155 MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 156 MIDDLE EAST AND AFRICA SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 157 MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 158 MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)
TABLE 159 MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 160 MIDDLE EAST AND AFRICA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 161 MIDDLE EAST AND AFRICA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 162 MIDDLE EAST AND AFRICA ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 163 MIDDLE EAST AND AFRICA MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 164 MIDDLE EAST AND AFRICA NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 165 MIDDLE EAST AND AFRICA APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 166 MIDDLE EAST AND AFRICA EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 167 MIDDLE EAST AND AFRICA INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 168 MIDDLE EAST AND AFRICA CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 169 MIDDLE EAST AND AFRICA ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 170 MIDDLE EAST AND AFRICA WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 171 MIDDLE EAST AND AFRICA ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 172 MIDDLE EAST AND AFRICA EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 173 MIDDLE EAST AND AFRICA DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 174 MIDDLE EAST AND AFRICA MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 175 MIDDLE EAST AND AFRICA AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 176 MIDDLE EAST AND AFRICA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 177 MIDDLE EAST AND AFRICA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 178 MIDDLE EAST AND AFRICA ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 179 MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)
TABLE 180 MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 181 MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 182 MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 183 MIDDLE EAST AND AFRICA B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 184 ISRAEL MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 185 ISRAEL OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 186 ISRAEL OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 187 ISRAEL OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 188 ISRAEL OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 189 ISRAEL BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 190 ISRAEL DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 191 ISRAEL MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 192 ISRAEL MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)
TABLE 193 ISRAEL MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 194 ISRAEL MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 195 ISRAEL BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 196 ISRAEL VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 197 ISRAEL VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 198 ISRAEL BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 199 ISRAEL WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 200 ISRAEL WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 201 ISRAEL BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 202 ISRAEL CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 203 ISRAEL CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 204 ISRAEL BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 205 ISRAEL GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 206 ISRAEL GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 207 ISRAEL BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 208 ISRAEL PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 209 ISRAEL PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 210 ISRAEL PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 211 ISRAEL BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 212 ISRAEL MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 213 ISRAEL MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 214 ISRAEL BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 215 ISRAEL CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 216 ISRAEL CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 217 ISRAEL BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 218 ISRAEL MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 219 ISRAEL SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 220 ISRAEL MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 221 ISRAEL MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)
TABLE 222 ISRAEL MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 223 ISRAEL PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 224 ISRAEL PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 225 ISRAEL ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 226 ISRAEL MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 227 ISRAEL NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 228 ISRAEL APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 229 ISRAEL EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 230 ISRAEL INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 231 ISRAEL CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 232 ISRAEL ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 233 ISRAEL WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 234 ISRAEL ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 235 ISRAEL EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 236 ISRAEL DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 237 ISRAEL MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 238 ISRAEL AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 239 ISRAEL MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 240 ISRAEL MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 241 ISRAEL ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 242 ISRAEL MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)
TABLE 243 ISRAEL MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 244 ISRAEL MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 245 ISRAEL MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 246 ISRAEL B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 247 SOUTH AFRICA MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 248 SOUTH AFRICA OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 249 SOUTH AFRICA OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 250 SOUTH AFRICA OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 251 SOUTH AFRICA OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 252 SOUTH AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 253 SOUTH AFRICA DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 254 SOUTH AFRICA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 255 SOUTH AFRICA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)
TABLE 256 SOUTH AFRICA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 257 SOUTH AFRICA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 258 SOUTH AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 259 SOUTH AFRICA VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 260 SOUTH AFRICA VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 261 SOUTH AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 262 SOUTH AFRICA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 263 SOUTH AFRICA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 264 SOUTH AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 265 SOUTH AFRICA CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 266 SOUTH AFRICA CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 267 SOUTH AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 268 SOUTH AFRICA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 269 SOUTH AFRICA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 270 SOUTH AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 271 SOUTH AFRICA PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 272 SOUTH AFRICA PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 273 SOUTH AFRICA PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 274 SOUTH AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 275 SOUTH AFRICA MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 276 SOUTH AFRICA MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 277 SOUTH AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 278 SOUTH AFRICA CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 279 SOUTH AFRICA CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 280 SOUTH AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 281 SOUTH AFRICA MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 282 SOUTH AFRICA SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 283 SOUTH AFRICA MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 284 SOUTH AFRICA MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)
TABLE 285 SOUTH AFRICA MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 286 SOUTH AFRICA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 287 SOUTH AFRICA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 288 SOUTH AFRICA ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 289 SOUTH AFRICA MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 290 SOUTH AFRICA NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 291 SOUTH AFRICA APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 292 SOUTH AFRICA EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 293 SOUTH AFRICA INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 294 SOUTH AFRICA CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 295 SOUTH AFRICA ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 296 SOUTH AFRICA WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 297 SOUTH AFRICA ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 298 SOUTH AFRICA EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 299 SOUTH AFRICA DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 300 SOUTH AFRICA MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 301 SOUTH AFRICA AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 302 SOUTH AFRICA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 303 SOUTH AFRICA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 304 SOUTH AFRICA ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 305 SOUTH AFRICA MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)
TABLE 306 SOUTH AFRICA MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 307 SOUTH AFRICA MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 308 SOUTH AFRICA MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 309 SOUTH AFRICA B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 310 LEBANON MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 311 LEBANON OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 312 LEBANON OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 313 LEBANON OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 314 LEBANON OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 315 LEBANON BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 316 LEBANON DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 317 LEBANON MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 318 LEBANON MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)
TABLE 319 LEBANON MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 320 LEBANON MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 321 LEBANON BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 322 LEBANON VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 323 LEBANON VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 324 LEBANON BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 325 LEBANON WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 326 LEBANON WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 327 LEBANON BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 328 LEBANON CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 329 LEBANON CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 330 LEBANON BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 331 LEBANON GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 332 LEBANON GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 333 LEBANON BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 334 LEBANON PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 335 LEBANON PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 336 LEBANON PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 337 LEBANON BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 338 LEBANON MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 339 LEBANON MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 340 LEBANON BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 341 LEBANON CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 342 LEBANON CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 343 LEBANON BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 344 LEBANON MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 345 LEBANON SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 346 LEBANON MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 347 LEBANON MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)
TABLE 348 LEBANON MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 349 LEBANON PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 350 LEBANON PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 351 LEBANON ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 352 LEBANON MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 353 LEBANON NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 354 LEBANON APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 355 LEBANON EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 356 LEBANON INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 357 LEBANON CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 358 LEBANON ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 359 LEBANON WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 360 LEBANON ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 361 LEBANON EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 362 LEBANON DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 363 LEBANON MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 364 LEBANON AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 365 LEBANON MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 366 LEBANON MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 367 LEBANON ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 368 LEBANON MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)
TABLE 369 LEBANON MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 370 LEBANON MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 371 LEBANON MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 372 LEBANON B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 373 U.A.E. MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 374 U.A.E. OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 375 U.A.E. OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 376 U.A.E. OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 377 U.A.E. OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 378 U.A.E. BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 379 U.A.E. DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 380 U.A.E. MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 381 U.A.E. MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)
TABLE 382 U.A.E. MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 383 U.A.E. MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 384 U.A.E. BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 385 U.A.E. VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 386 U.A.E. VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 387 U.A.E. BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 388 U.A.E. WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 389 U.A.E. WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 390 U.A.E. BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 391 U.A.E. CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 392 U.A.E. CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 393 U.A.E. BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 394 U.A.E. GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 395 U.A.E. GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 396 U.A.E. BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 397 U.A.E. PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 398 U.A.E. PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 399 U.A.E. PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 400 U.A.E. BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 401 U.A.E. MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 402 U.A.E. MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 403 U.A.E. BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 404 U.A.E. CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 405 U.A.E. CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 406 U.A.E. BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 407 U.A.E. MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 408 U.A.E. SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 409 U.A.E. MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 410 U.A.E. MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)
TABLE 411 U.A.E. MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 412 U.A.E. PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 413 U.A.E. PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 414 U.A.E. ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 415 U.A.E. MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 416 U.A.E. NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 417 U.A.E. APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 418 U.A.E. EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 419 U.A.E. INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 420 U.A.E. CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 421 U.A.E. ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 422 U.A.E. WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 423 U.A.E. ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 424 U.A.E. EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 425 U.A.E. DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 426 U.A.E. MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 427 U.A.E. AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 428 U.A.E. MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 429 U.A.E. MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 430 U.A.E. ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 431 U.A.E. MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)
TABLE 432 U.A.E. MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 433 U.A.E. MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 434 U.A.E. MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 435 U.A.E. B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 436 KUWAIT MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 437 KUWAIT OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 438 KUWAIT OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 439 KUWAIT OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 440 KUWAIT OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 441 KUWAIT BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 442 KUWAIT DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 443 KUWAIT MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 444 KUWAIT MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)
TABLE 445 KUWAIT MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 446 KUWAIT MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 447 KUWAIT BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 448 KUWAIT VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 449 KUWAIT VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 450 KUWAIT BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 451 KUWAIT WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 452 KUWAIT WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 453 KUWAIT BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 454 KUWAIT CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 455 KUWAIT CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 456 KUWAIT BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 457 KUWAIT GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 458 KUWAIT GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 459 KUWAIT BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 460 KUWAIT PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 461 KUWAIT PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 462 KUWAIT PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 463 KUWAIT BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 464 KUWAIT MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 465 KUWAIT MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 466 KUWAIT BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 467 KUWAIT CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 468 KUWAIT CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 469 KUWAIT BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 470 KUWAIT MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 471 KUWAIT SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 472 KUWAIT MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 473 KUWAIT MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)
TABLE 474 KUWAIT MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 475 KUWAIT PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 476 KUWAIT PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 477 KUWAIT ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 478 KUWAIT MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 479 KUWAIT NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 480 KUWAIT APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 481 KUWAIT EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 482 KUWAIT INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 483 KUWAIT CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 484 KUWAIT ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 485 KUWAIT WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 486 KUWAIT ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 487 KUWAIT EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 488 KUWAIT DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 489 KUWAIT MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 490 KUWAIT AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 491 KUWAIT MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 492 KUWAIT MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 493 KUWAIT ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 494 KUWAIT MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)
TABLE 495 KUWAIT MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 496 KUWAIT MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 497 KUWAIT MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 498 KUWAIT B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 499 REST OF MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
图片列表
FIGURE 1 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: DATA TRIANGULATION
FIGURE 3 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: MIDDLE EAST & AFRICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: DBMR MARKET POSITION GRID
FIGURE 8 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 9 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: SEGMENTATION
FIGURE 11 INCREASING MEDICINAL USE AND LEGALIZATION OF MEDICAL CANNABIS ARE EXPECTED TO DRIVE THE MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET IN THE FORECAST PERIOD OF 2023 TO 2030
FIGURE 12 PRODUCT SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET IN 2023 AND 2030
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET
FIGURE 14 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY PRODUCT, 2022
FIGURE 15 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY PRODUCT, 2023-2030 (USD MILLION)
FIGURE 16 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY PRODUCT, CAGR (2023-2030)
FIGURE 17 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 18 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY SPECIES, 2022
FIGURE 19 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY SPECIES, 2023-2030 (USD MILLION)
FIGURE 20 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY SPECIES, CAGR (2023-2030)
FIGURE 21 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY SPECIES, LIFELINE CURVE
FIGURE 22 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY DERIVATIVES, 2022
FIGURE 23 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY DERIVATIVES, 2023-2030 (USD MILLION)
FIGURE 24 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY DERIVATIVES, CAGR (2023-2030)
FIGURE 25 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY DERIVATIVES, LIFELINE CURVE
FIGURE 26 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY APPLICATION, 2022
FIGURE 27 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY APPLICATION , 2023-2030 (USD MILLION)
圖 28 中東和非洲醫用大麻市場：按應用、複合年增長率（2023-2030 年）
圖 29 中東和非洲醫用大麻市場：按應用、生命線曲線
圖 30 中東和非洲醫用大麻市場：依給藥途徑，2022 年
圖 31 中東和非洲醫用大麻市場：依給藥途徑，2023-2030 年（百萬美元）
圖 32 中東及非洲醫用大麻市場：依給藥途徑、複合年增長率（2023-2030 年）
圖 33 中東及非洲醫用大麻市場：依給藥途徑、生命線曲線
圖 34 中東和非洲醫用大麻市場：依治療類型，2022 年
圖 35 中東和非洲醫用大麻市場：按治療類型，2023-2030 年（百萬美元）
圖 36 中東和非洲醫用大麻市場：依治療類型、複合年增長率（2023-2030 年）
圖 37 中東和非洲醫用大麻市場：依治療類型、生命線曲線
圖 38 中東和非洲醫用大麻市場：按最終用戶劃分，2022 年
圖 39 中東和非洲醫用大麻市場：按最終用戶劃分，2023-2030 年（百萬美元）
圖 40 中東和非洲醫用大麻市場：按最終用戶劃分，複合年增長率（2023-2030 年）
圖 41 中東和非洲醫用大麻市場：依最終用戶、生命線曲線
圖 42 中東和非洲醫用大麻市場：按分銷管道劃分，2022 年
圖 43 中東和非洲醫用大麻市場：按分銷管道劃分，2023-2030 年（百萬美元）
圖 44 中東和非洲醫用大麻市場：按分銷管道、複合年增長率（2023-2030 年）
圖 45 中東和非洲醫用大麻市場：按分銷管道、生命線曲線
圖 46 中東和非洲醫用大麻市場：快照（2022 年）
圖 47 中東和非洲醫用大麻市場：按國家劃分（2022 年）
圖 48 中東和非洲醫用大麻市場：按國家劃分（2023 年和 2030 年）
圖 49 中東和非洲醫用大麻市場：按國家劃分（2022 年和 2030 年）
圖 50 中東和非洲醫用大麻市場：按產品（2023-2030 年）
圖51 中東和非洲醫用大麻市場：2022年公司份額（％）
研究方法
数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。该阶段包括通过各种来源和策略获取市场信息或相关数据。它包括提前检查和规划从过去获得的所有数据。它同样包括检查不同信息源中出现的信息不一致。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。要了解更多信息，请请求分析师致电或下拉您的询问。
DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析和主要（行业专家）验证。数据模型包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、专利分析、定价分析、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息，请向我们的行业专家咨询。
可定制
Data Bridge Market Research 是高级形成性研究领域的领导者。我们为向现有和新客户提供符合其目标的数据和分析而感到自豪。报告可定制，包括目标品牌的价格趋势分析、了解其他国家的市场（索取国家列表）、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表（事实手册）中的数据，或者可以帮助您根据报告中的数据集创建演示文稿。
